Whittemore Peterson Institute
The Whittemore Peterson Institute (WPI) is a nonprofit center based in Reno, Nevada, dedicated to the support of those with a spectrum of neuro-immune diseases (NIDs), including myalgic encephalomyelitis and fibromyalgia, via research, education, and advocacy. It was founded by Annette Whittemore, in 2005, in honor of an impacted family member and Dr Daniel Peterson, the doctor who diagnosed and treated her.
Clinic[edit | edit source]
Rebrand[edit | edit source]
In February 2016 the Whittemore Peterson Institute announced it was changing its name to the Nevada Center for Biomedical Research. In January 2019, due to restructuring of the research program, the center returned to its original name, the Whittemore Peterson Institute.
Notable studies[edit | edit source]
XMRV[edit | edit source]
An October 2009 paper by Vincent Lombardi, Francis Ruscetti, Jaydip Das Gupta, Max Pfost, Kathryn S. Hagen, Daniel Peterson, Sandra Ruscetti, Rachel K. Bagni, Cari Petrow-Sadowski, Bert Gold, Michael Dean, Robert Silverman Judy Mikovits entitled "Detection of an Infectious Retrovirus, XMRV, in Blood Cells of Patients with Chronic Fatigue Syndrome" claimed to have found a link between chronic fatigue syndrome and the presence of the retrovirus. The paper's primary authors were at that time based at the Whittemore Peterson Institute (WPI) in Reno, Nevada, United States. The WPI soon began offering a controversial commercial XMRV testing service.
Other labs around the world were unable to detect XMRV in their patient samples. In July 2011 the journal issued an editorial expression of concern about the paper.
Online presence[edit | edit source]
- Wikipedia - Nevada Center for Biomedical Research
- Webpage - Nevada Center for Biomedical Research
- Facebook - Nevada Center for Biomedical Research
Notable people[edit | edit source]
See also[edit | edit source]
References[edit | edit source]
- NVCBR. "About Us". Whittemore Peterson Institute. Retrieved Jan 17, 2019.
- Facebook announcement
- WPI. "NVCBR Latest News". Whittemore Peterson Institute. Retrieved Jan 17, 2019.
- Detection of an Infectious Retrovirus, XMRV, in Blood Cells of Patients with Chronic Fatigue Syndrome
- WPI-Licensed Test for XMRV & Variants Now Available
- XMRV testing in the UK
- Editorial Expression of Concern
- Chronic fatigue syndrome-XMRV paper retracted by Science, completely this time
- The scientist who put the nail in XMRV's coffin
- PLAGUE – The Update on XMRV
- Tracking retractions as a window into the scientific process Chronic fatigue syndrome researcher Mikovits, who championed link to XMRV, to publish book
- Wikipedia - XMRV - Chronic fatigue syndrome
- Final Study Confirms: Virus Not Implicated in Chronic Fatigue Syndrome
chronic fatigue syndrome (CFS) - A controversial term, invented by the U.S. Centers for Disease Control, that generally refers to a collection of symptoms as “fatigue”. There have been multiple attempts to come up with a set of diagnostic criteria to define this term, but few of those diagnostic criteria are currently in use. Previous attempts to define this term include the Fukuda criteria and the Oxford criteria. Some view the term as a useful diagnostic category for people with long-term fatigue of unexplained origin. Others view the term as a derogatory term borne out of animus towards patients. Some view the term as a synonym of myalgic encephalomyelitis, while others view myalgic encephalomyelitis as a distinct disease.